Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Nektar Therapeutics
Nektar Therapeutics
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Ingredients
Therapeutic: rezpegaldesleukin for dermatitis
Atopic dermatitis remains an unmet medical need, with better and more effective treatments still required for the one in 10 people who are affected
Regulatory
Anticancer agent – etirinotecan pegol
Nektar Therapeutics has developed a pegylated tetrameric derivative of irinotecan that is designed to preferentially penetrate tumour vasculature ahead of normal vasculature
Pharmaceutical
Ivan Gergel becomes SVP, Drug Development & Chief Medical Officer at Nektar Therapeutics
Joins the company from Endo Pharmaceuticals
Regulatory
Opioid-induced constipation – naloxegol
About half of all patients taking opioids commonly experience constipation
Subscribe now